Smith & Nephew plc (LON:SN.)
| Market Cap | 10.55B |
|---|---|
| Revenue | 0 |
| Gross Profit | 0 |
| Shares Out | 872.46M |
| EPS (ttm) | |
| PE Ratio | 0.0000 |
| Forward PE | 0.0000 |
| Dividend Rate (ttm) | 0.2890 |
| Dividend Yield | 0.0239 |
| Trading Day | Jun 10 |
|---|---|
| Last Price | £12.09 |
| Previous Close | £12.09 |
| Change (£) | 0 |
| Change (%) | 0% |
| Day's Open | 12.09 |
| Day's Range | 12.09 - 12.32 |
| Day's Volume | 0 |
| 52 Week Range | 11.51 - 16.01 |
About Smith & Nephew plc
Smith+Nephew is a portfolio medical technology business that exists to restore people's bodies and their self-belief by using technology to take the limits off living. It calls this purpose 'Life Unlimited'.
Its 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of its product portfolio, and the invention and application of new technologies across its three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, it now operates in more than 100 countries, and generated annual sales of $4.6 billion in 2020.
News
No news found.Quick info
Watford
Hertfordshire
WD18 8YE
Smith & Nephew plc dividends
Total Valuation
Smith & Nephew plc has a market cap or net worth of £10.55 billion. The enterprise value is £0.
Important Dates
Share Statistics
Smith & Nephew plc has 872.46 million shares outstanding.
Valuation Ratios
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Smith & Nephew plc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.0652%. The beta is 0.0000, so Smith & Nephew plc's price volatility has been lower than the market average.
Income Statement
In the last 12 months, Smith & Nephew plc had revenue of £0 and earned £0 in profits. Earnings per share was £.